| 000 | 01516 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516024649.0 | ||
| 264 | 0 | _c20110916 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1470-8728 | ||
| 024 | 7 |
_a10.1042/BJ20110040 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTan, Shixiong | |
| 245 | 0 | 0 |
_aNext-generation Akt inhibitors provide greater specificity: effects on glucose metabolism in adipocytes. _h[electronic resource] |
| 260 |
_bThe Biochemical journal _cApr 2011 |
||
| 300 |
_a539-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a3T3-L1 Cells |
| 650 | 0 | 4 |
_aAdipocytes _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 |
_aGlucose Transporter Type 4 _xmetabolism |
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 3-Ring _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein Transport _xdrug effects |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSubstrate Specificity _xdrug effects |
| 700 | 1 | _aNg, Yvonne | |
| 700 | 1 | _aJames, David E | |
| 773 | 0 |
_tThe Biochemical journal _gvol. 435 _gno. 2 _gp. 539-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1042/BJ20110040 _zAvailable from publisher's website |
| 999 |
_c20624325 _d20624325 |
||